Association of RASSF1A, DCR2, and CASP8 Methylation with Survival in Neuroblastoma: A Pooled Analysis Using Reconstructed Individual Patient Data
Neuroblastoma (NB) is a heterogeneous tumor affecting children. It shows a wide spectrum of clinical outcomes; therefore, development of risk stratification is critical to provide optimum treatment. Since epigenetic alterations such as DNA methylation have emerged as an important feature of both dev...
Main Authors: | Waleed M. Hassan, Mohamed S. Bakry, Timo Siepmann, Ben Illigens |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2020/7390473 |
Similar Items
-
Frequent promoter hypermethylation of RASSF1A and CASP8 in neuroblastoma
by: Encío Ignacio, et al.
Published: (2006-10-01) -
The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma
by: Djos Anna, et al.
Published: (2012-06-01) -
Methylation Status of NANOG1, RASSF1A, SFN, CASP8, WIF1,CTSL2 Genes in Iranian Breast Cancer Patients
by: Ali Motevalizadeh Ardekani, et al.
Published: (2017-01-01) -
CASP8 SNP D302H (rs1045485) is associated with worse survival in MYCN-amplified neuroblastoma patients.
by: Ali Rihani, et al.
Published: (2014-01-01) -
Casp8AP2 DNA Methylation Regulated Drug Resistance
by: Mei-Yu Pai, et al.
Published: (2013)